Global Boronate Affinity Tests Market-Industry Analysis, Growth, Trends and Forecast- 2019-2027


Global Boronate Affinity Tests Market size is expected to reach US$ 8.71 Bn. by year 2027 at a CAGR of 9.32% during the forecast period.

Boronate affinity Tests are widely used to measure the total glycated haemoglobin, consisting of HbA1c and other Hb variants regardless of the charge. It is a chromatographic technique for the quantitation of glycosylated haemoglobin using a boronic acid affinity support. The glycosylated haemoglobin gets bound to the immobilized boronic acid, which helps them to separate from non-glycosylated haemoglobin. It measures the total glycosylated haemoglobin (GHb), including HBA1c and Hb glycated at other sites. This test is conducted on people with Type 1 and Type 2 diabetes.

Global Boronate Affinity Tests Market Dynamics

Increasing number of diabetic’s patients in China, India, Brazil, and South Africa is expected to drive the market for The Boronate affinity tests in forecast period. As on 2020, number of diabetics’ patients in China, India, Brazil and South Africa was xx MN, xx MN, xx MN and XX MN respectively and total number of diabetics patients in these four countries is expected to be XXX MN by 2027.

The increasing diabetic population in these focused countries are expected to drive the market for Boronate affinity-based HBA1c laboratory tests. Country wise analysis of increment in the patients and the current tests in the industry are analysed with the share of Boronate affinity-based HBA1c.

According to CDC, around 34.2 million people were suffering from diabetes in 2019, while 88 million US adults were prediabetic. Routine tests for corporate employees by the company and government wellness programs have increased the market for Boronate affinity testing.

The migration of R&D facilities from western countries to the developing nations in APAC due to low labour costs is expected to increase demand for Boronate affinity chromatography products and similar other laboratory equipment in the forecast period. The rapidly increasing chemical industry and investments from private investors is also having a positive impact on the market.

Global Boronate Affinity Tests Market Segmentation

The market is segmented as: By technology, by indication, by region

Global Boronate Affinity Tests market, by technology

• Boronate Affinity Chromatography
• Boronate Affinity high-performance liquid chromatography
• Ion-exchange HPLC

Global Boronate Affinity Tests Market

To know about the Research Methodology :- Request Free Sample Report

Technology Segment Analysis

The ion-exchange high performance liquid chromatography (HPLC) segment accounted for the largest share of the global Boronate Affinity Tests market in 2019.This segment is expected to expand at a significant CAGR during the forecast period. High Performance Liquid Chromatography increases ionic strength of buffer, identifies variants, and consumes less time. Hence, the segment is likely to dominate the market during the forecast period.

Scope of the Global Boronate Affinity Tests Market: Inquire before buying


Global Boronate Affinity Tests Market, by Indication

• Type 1 diabetes
• Type 2 diabetes

Global Boronate Affinity Tests Market, by Region

Global Boronate Affinity Tests Market1

North America to dominate the Global Boronate Affinity Tests Market

North America is expected to lead the market in the forecast period. The advancements in accurate diagnostic tests and adoption of advanced techniques has lead the country to top in the Boronate affinity tests market. Increase in diabetic population, Increase in awareness about this test and rise in physician prescriptions for this test are expected to elevate the market in this region.

Laboratory equipment manufacturers of this test are entering into partnership with laboratories, thereby driving the market.

Increase in funding by the government authorities, favourable reimbursement policies and an increase in diabetic and geriatric population is leading to a rise in number of laboratories for Boronate affinity tests.

The objective of the report is to present a comprehensive analysis of the Global Boronate Affinity Tests Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Boronate Affinity Tests Market dynamics, structure by analyzing the market segments and project the Global Boronate Affinity Tests size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Boronate Affinity Tests Market make the report investor’s guide.

Leading players operating the Global Boronate Affinity Tests Market

• Abbott Laboratories
• A. Menarini Diagnostics s.r.l
• GREENCORSS MEDIS Corp
• Alere Inc.
• Trinity Biotech
• HUMAN DIgnostics
• HemoCue
• ARKRAY, Inc.
• Beckman Coulter, Inc
• Bio-Rad Laboratories, Inc.
• Diazyme Laboratories, Inc.
• EKF Diagnostics Holdings plc
• OSANG Healthcare Co. Ltd
• PTS Diagnostics
• Roche Diagnostics
• Siemens Healthineers
• Tosoh Bioscience, Inc.
• Trinity Biotech plc 




Global Boronate Affinity Tests Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Boronate Affinity Tests Market Size, by Market Value (US$ Mn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global Boronate Affinity Tests Market Analysis and Forecast
6.1. Boronate Affinity Tests Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Boronate Affinity Tests Market Analysis and Forecast, By Indication
7.1. Introduction and Definition
7.2. Key Findings
7.3. Boronate Affinity Tests Market Value Share Analysis, By Indication
7.4. Boronate Affinity Tests Market Size (US$ Mn) Forecast, By Indication
7.5. Boronate Affinity Tests Market Analysis, By Indication
7.6. Boronate Affinity Tests Market Attractiveness Analysis, By Indication

8. Global Boronate Affinity Tests Market Analysis and Forecast, By Technology
8.1. Introduction and Definition
8.2. Key Findings
8.3. Boronate Affinity Tests Market Value Share Analysis, By Technology
8.4. Boronate Affinity Tests Market Size (US$ Mn) Forecast, By Technology
8.5. Boronate Affinity Tests Market Analysis, By Technology
8.6. Boronate Affinity Tests Market Attractiveness Analysis, By Technology

9. Global Boronate Affinity Tests Market Analysis, by Region
9.1. Boronate Affinity Tests Market Value Share Analysis, by Region
9.2. Boronate Affinity Tests Market Size (US$ Mn) Forecast, by Region
9.3. Boronate Affinity Tests Market Attractiveness Analysis, by Region

10. North America Boronate Affinity Tests Market Analysis
10.1. Key Findings
10.2. North America Boronate Affinity Tests Market Overview
10.3. North America Boronate Affinity Tests Market Value Share Analysis, By Indication
10.4. North America Boronate Affinity Tests Market Forecast, By Indication
10.4.1. Type 1 diabetes
10.4.2. Type 2 diabetes
10.5. North America Boronate Affinity Tests Market Value Share Analysis, By Technology
10.6. North America Boronate Affinity Tests Market Forecast, By Technology
10.6.1. Boronate Affinity Chromatography
10.6.2. Boronate Affinity high-performance liquid chromatography
10.6.3. Ion-exchange HPLC
10.7. North America Boronate Affinity Tests Market Value Share Analysis, by Country
10.8. North America Boronate Affinity Tests Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.8.3. Mexico
10.9. North America Boronate Affinity Tests Market Analysis, by Country
10.10. U.S. Boronate Affinity Tests Market Forecast, By Indication
10.10.1. Type 1 diabetes
10.10.2. Type 2 diabetes
10.11. U.S. Boronate Affinity Tests Market Forecast, By Technology
10.11.1. Boronate Affinity Chromatography
10.11.2. Boronate Affinity high-performance liquid chromatography
10.11.3. Ion-exchange HPLC
10.12. Canada Boronate Affinity Tests Market Forecast, By Indication
10.12.1. Type 1 diabetes
10.12.2. Type 2 diabetes

10.13. Canada Boronate Affinity Tests Market Forecast, By Technology
10.13.1. Boronate Affinity Chromatography
10.13.2. Boronate Affinity high-performance liquid chromatography
10.13.3. Ion-exchange HPLC

10.14. Mexico Boronate Affinity Tests Market Forecast, By Indication
10.14.1. Type 1 diabetes
10.14.2. Type 2 diabetes
10.15. Mexico Boronate Affinity Tests Market Forecast, By Technology
10.15.1. Boronate Affinity Chromatography
10.15.2. Boronate Affinity high-performance liquid chromatography
10.15.3. Ion-exchange HPLC
10.16. North America Boronate Affinity Tests Market Attractiveness Analysis
10.16.1. By Indication
10.16.2. By Technology
10.17. PEST Analysis
10.18. Key Trends
10.19. Key Developments

11. Europe Boronate Affinity Tests Market Value Share Analysis, By Indication
11.1. Europe Boronate Affinity Tests Market Forecast, By Indication
11.1.1. Type 1 diabetes
11.1.2. Type 2 diabetes
11.2. Europe Boronate Affinity Tests Market Forecast, By Technology
11.2.1. Boronate Affinity Chromatography
11.2.2. Boronate Affinity high-performance liquid chromatography
11.2.3. Ion-exchange HPLC
11.3. Europe Boronate Affinity Tests Market Value Share Analysis, by Country
11.4. Europe Boronate Affinity Tests Market Forecast, by Country
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Sweden
11.4.7. CIS countries
11.4.8. Rest of Europe
11.5. Germany Boronate Affinity Tests Market Forecast, By Indication
11.5.1. Type 1 diabetes
11.5.2. Type 2 diabetes
11.6. Germany Boronate Affinity Tests Market Forecast, By Technology
11.6.1. Boronate Affinity Chromatography
11.6.2. Boronate Affinity high-performance liquid chromatography
11.6.3. Ion-exchange HPLC
11.7. U.K. Boronate Affinity Tests Market Forecast, By Indication
11.7.1. Type 1 diabetes
11.7.2. Type 2 diabetes
11.8. U.K. Boronate Affinity Tests Market Forecast, By Technology
11.8.1. Boronate Affinity Chromatography
11.8.2. Boronate Affinity high-performance liquid chromatography
11.8.3. Ion-exchange HPLC
12. France Boronate Affinity Tests Market Forecast, By Indication
12.1.1. Type 1 diabetes
12.1.2. Type 2 diabetes
12.2. France Boronate Affinity Tests Market Forecast, By Technology
12.2.1. Boronate Affinity Chromatography
12.2.2. Boronate Affinity high-performance liquid chromatography
12.2.3. Ion-exchange HPLC
12.3. Italy Boronate Affinity Tests Market Forecast, By Indication
12.3.1. Type 1 diabetes
12.3.2. Type 2 diabetes
12.4. Italy Boronate Affinity Tests Market Forecast, By Technology
12.4.1. Boronate Affinity Chromatography
12.4.2. Boronate Affinity high-performance liquid chromatography
12.4.3. Ion-exchange HPLC
12.5. Spain Boronate Affinity Tests Market Forecast, By Indication
12.5.1. Type 1 diabetes
12.5.2. Type 2 diabetes
12.6. Spain Boronate Affinity Tests Market Forecast, By Technology
12.6.1. Boronate Affinity Chromatography
12.6.2. Boronate Affinity high-performance liquid chromatography
12.6.3. Ion-exchange HPLC
12.7. Sweden Boronate Affinity Tests Market Forecast, By Indication
12.7.1. Type 1 diabetes
12.7.2. Type 2 diabetes

12.8. Sweden Boronate Affinity Tests Market Forecast, By Technology
12.8.1. Boronate Affinity Chromatography
12.8.2. Boronate Affinity high-performance liquid chromatography
12.8.3. Ion-exchange HPLC
12.9. CIS countries Boronate Affinity Tests Market Forecast, By Indication
12.9.1. Type 1 diabetes
12.9.2. Type 2 diabetes
12.10. CIS countries Boronate Affinity Tests Market Forecast, By Technology
12.10.1. Boronate Affinity Chromatography
12.10.2. Boronate Affinity high-performance liquid chromatography
12.10.3. Ion-exchange HPLC
12.11. Rest of Europe Boronate Affinity Tests Market Forecast, By Indication
12.11.1. Type 1 diabetes
12.11.2. Type 2 diabetes
12.12. Rest of Europe Boronate Affinity Tests Market Forecast, By Technology
12.12.1. Boronate Affinity Chromatography
12.12.2. Boronate Affinity high-performance liquid chromatography
12.12.3. Ion-exchange HPLC
12.13. Europe Boronate Affinity Tests Market Attractiveness Analysis
12.13.1. By Technology
12.13.2. By Indication
12.14. PEST Analysis
12.15. Key Trends
12.16. Key Developments

13. Asia Pacific Boronate Affinity Tests Market Analysis
13.1. Key Findings
13.2. Asia Pacific Boronate Affinity Tests Market Overview
13.3. Asia Pacific Boronate Affinity Tests Market Value Share Analysis, By Indication
13.4. Asia Pacific Boronate Affinity Tests Market Forecast, By Indication
13.4.1. Type 1 diabetes
13.4.2. Type 2 diabetes
13.5. Asia Pacific Boronate Affinity Tests Market Value Share Analysis, By Indication
13.6. Asia Pacific Boronate Affinity Tests Market Forecast, By Technology
13.6.1. Boronate Affinity Chromatography
13.6.2. Boronate Affinity high-performance liquid chromatography
13.6.3. Ion-exchange HPLC
13.7. Asia Pacific Boronate Affinity Tests Market Value Share Analysis, by Country
13.8. Asia Pacific Boronate Affinity Tests Market Forecast, by Country
13.8.1. China
13.8.2. India
13.8.3. Japan
13.8.4. South Korea
13.8.5. Australia
13.8.6. ASEAN
13.8.7. Rest of Asia Pacific
13.9. Asia Pacific Boronate Affinity Tests Market Analysis, by Country
13.10. China Boronate Affinity Tests Market Forecast, By Indication
13.10.1. Type 1 diabetes
13.10.2. Type 2 diabetes
13.11. China Boronate Affinity Tests Market Forecast, By Technology
13.11.1. Boronate Affinity Chromatography
13.11.2. Boronate Affinity high-performance liquid chromatography
13.11.3. Ion-exchange HPLC
13.12. India Boronate Affinity Tests Market Forecast, By Indication
13.12.1. Type 1 diabetes
13.12.2. Type 2 diabetes

13.13. India Boronate Affinity Tests Market Forecast, By Technology
13.13.1. Boronate Affinity Chromatography
13.13.2. Boronate Affinity high-performance liquid chromatography
13.13.3. Ion-exchange HPLC
13.14. Japan Boronate Affinity Tests Market Forecast, By Indication
13.14.1. Type 1 diabetes
13.14.2. Type 2 diabetes

13.15. Japan Boronate Affinity Tests Market Forecast, By Technology
13.15.1. Boronate Affinity Chromatography
13.15.2. Boronate Affinity high-performance liquid chromatography
13.15.3. Ion-exchange HPLC
13.16. South Korea Boronate Affinity Tests Market Forecast, By Indication
13.16.1. Type 1 diabetes
13.16.2. Type 2 diabetes
13.17. South Korea Boronate Affinity Tests Market Forecast, By Technology
13.17.1. Boronate Affinity Chromatography
13.17.2. Boronate Affinity high-performance liquid chromatography
13.17.3. Ion-exchange HPLC
13.18. Australia Boronate Affinity Tests Market Forecast, By Indication
13.18.1. Type 1 diabetes
13.18.2. Type 2 diabetes
13.19. Australia Boronate Affinity Tests Market Forecast, By Technology
13.19.1. Boronate Affinity Chromatography
13.19.2. Boronate Affinity high-performance liquid chromatography
13.19.3. Ion-exchange HPLC
13.20. ASEAN Boronate Affinity Tests Market Forecast, By Indication
13.20.1. Type 1 diabetes
13.20.2. Type 2 diabetes

13.21. ASEAN Boronate Affinity Tests Market Forecast, By Technology
13.21.1. Boronate Affinity Chromatography
13.21.2. Boronate Affinity high-performance liquid chromatography
13.21.3. Ion-exchange HPLC
13.22. Rest of Asia Pacific Boronate Affinity Tests Market Forecast, By Indication
13.22.1. Type 1 diabetes
13.22.2. Type 2 diabetes
13.23. Rest of Asia Pacific Boronate Affinity Tests Market Forecast, By Technology
13.23.1. Boronate Affinity Chromatography
13.23.2. Boronate Affinity high-performance liquid chromatography
13.23.3. Ion-exchange HPLC
13.24. Asia Pacific Boronate Affinity Tests Market Attractiveness Analysis
13.24.1. By Indication
13.24.2. By Technology
13.25. PEST Analysis
13.26. Key Trends
13.27. Key Developments

14. Middle East & Africa Boronate Affinity Tests Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Boronate Affinity Tests Market Overview
14.3. Middle East & Africa Boronate Affinity Tests Market Value Share Analysis, By Indication
14.4. Middle East & Africa Boronate Affinity Tests Market Forecast, By Indication
14.4.1. Type 1 diabetes
14.4.2. Type 2 diabetes

14.5. Middle East & Africa Boronate Affinity Tests Market Forecast, By Technology
14.5.1. Boronate Affinity Chromatography
14.5.2. Boronate Affinity high-performance liquid chromatography
14.5.3. Ion-exchange HPLC
14.6. Middle East & Africa Boronate Affinity Tests Market Value Share Analysis, by Country
14.7. Middle East & Africa Boronate Affinity Tests Market Forecast, by Country
14.7.1. GCC Countries
14.7.2. South Africa
14.7.3. Nigeria
14.7.4. Egypt
14.7.5. Rest of Middle East & Africa
14.8. Middle East & Africa Boronate Affinity Tests Market Analysis, by Country
14.9. GCC Countries Boronate Affinity Tests Market Forecast, By Indication
14.9.1. Type 1 diabetes
14.9.2. Type 2 diabetes

14.10. GCC Countries Boronate Affinity Tests Market Forecast, By Technology
14.10.1. Boronate Affinity Chromatography
14.10.2. Boronate Affinity high-performance liquid chromatography
14.10.3. Ion-exchange HPLC
14.11. South Africa Boronate Affinity Tests Market Forecast, By Indication
14.11.1. Type 1 diabetes
14.11.2. Type 2 diabetes

14.12. South Africa Boronate Affinity Tests Market Forecast, By Technology
14.12.1. Boronate Affinity Chromatography
14.12.2. Boronate Affinity high-performance liquid chromatography
14.12.3. Ion-exchange HPLC
14.13. Nigeria Boronate Affinity Tests Market Forecast, By Indication
14.13.1. Type 1 diabetes
14.13.2. Type 2 diabetes
14.14. Nigeria Boronate Affinity Tests Market Forecast, By Technology
14.14.1. Boronate Affinity Chromatography
14.14.2. Boronate Affinity high-performance liquid chromatography
14.14.3. Ion-exchange HPLC
14.15. Egypt Boronate Affinity Tests Market Forecast, By Indication
14.15.1. Type 1 diabetes
14.15.2. Type 2 diabetes
14.16. Egypt Boronate Affinity Tests Market Forecast, By Technology
14.16.1. Boronate Affinity Chromatography
14.16.2. Boronate Affinity high-performance liquid chromatography
14.16.3. Ion-exchange HPLC
14.17. Rest of Middle East & Africa Boronate Affinity Tests Market Forecast, By Indication
14.17.1. Type 1 diabetes
14.17.2. Type 2 diabetes
14.18. Rest of Middle East & Africa Boronate Affinity Tests Market Forecast, By Technology
14.18.1. Boronate Affinity Chromatography
14.18.2. Boronate Affinity high-performance liquid chromatography
14.18.3. Ion-exchange HPLC
14.19. Middle East & Africa Boronate Affinity Tests Market Attractiveness Analysis
14.19.1. By Indication
14.19.2. By Technology
14.20. PEST Analysis
14.21. Key Trends
14.22. Key Developments

15. South America Boronate Affinity Tests Market Analysis
15.1. Key Findings
15.2. South America Boronate Affinity Tests Market Overview
15.3. South America Boronate Affinity Tests Market Value Share Analysis, By Indication
15.4. South America Boronate Affinity Tests Market Forecast, By Indication
15.4.1. Type 1 diabetes
15.4.2. Type 2 diabetes

15.5. South America Boronate Affinity Tests Market Forecast, By Technology
15.5.1. Boronate Affinity Chromatography
15.5.2. Boronate Affinity high-performance liquid chromatography
15.5.3. Ion-exchange HPLC
15.6. South America Boronate Affinity Tests Market Value Share Analysis, by Country
15.7. South America Boronate Affinity Tests Market Forecast, by Country
15.7.1. Brazil
15.7.2. Colombia
15.7.3. Argentina
15.7.4. Rest of South America
15.8. South America Boronate Affinity Tests Market Analysis, by Country
15.9. Brazil Boronate Affinity Tests Market Forecast, By Indication
15.9.1. Type 1 diabetes
15.9.2. Type 2 diabetes

15.10. Brazil Boronate Affinity Tests Market Forecast, By Technology
15.10.1. Boronate Affinity Chromatography
15.10.2. Boronate Affinity high-performance liquid chromatography
15.10.3. Ion-exchange HPLC
15.11. Colombia Boronate Affinity Tests Market Forecast, By Indication
15.11.1. Type 1 diabetes
15.11.2. Type 2 diabetes

15.12. Colombia Boronate Affinity Tests Market Forecast, By Technology
15.12.1. Boronate Affinity Chromatography
15.12.2. Boronate Affinity high-performance liquid chromatography
15.12.3. Ion-exchange HPLC
15.13. Argentina Boronate Affinity Tests Market Forecast, By Indication
15.13.1. Type 1 diabetes
15.13.2. Type 2 diabetes
15.14. Argentina Boronate Affinity Tests Market Forecast, By Technology
15.14.1. Boronate Affinity Chromatography
15.14.2. Boronate Affinity high-performance liquid chromatography
15.14.3. Ion-exchange HPLC
15.15. Rest of South America Boronate Affinity Tests Market Forecast, By Indication
15.15.1. Type 1 diabetes
15.15.2. Type 2 diabetes
15.16. Rest of South America Boronate Affinity Tests Market Forecast, By Technology
15.16.1. Boronate Affinity Chromatography
15.16.2. Boronate Affinity high-performance liquid chromatography
15.16.3. Ion-exchange HPLC
15.17. South America Boronate Affinity Tests Market Attractiveness Analysis
15.17.1. By Indication
15.17.2. By Technology
15.18. PEST Analysis
15.19. Key Trends
15.20. Key Developments

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix

16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications, and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration

16.3. Company Profiles: Key Players
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview
16.3.2. Financial Overview
16.3.2.1. Product Portfolio
16.3.2.2. Business Strategy
16.3.2.3. Recent Developments
16.3.2.4. Development Footprint
16.3.3. A. Menarini Diagnostics s.r.l
16.3.4. GREENCORSS MEDIS Corp
16.3.5. Alere Inc.
16.3.6. Trinity Biotech
16.3.7. HUMAN DIgnostics
16.3.8. HemoCue
16.3.9. ARKRAY, Inc.
16.3.10. Beckman Coulter, Inc
16.3.11. Bio-Rad Laboratories, Inc.
16.3.12. Diazyme Laboratories, Inc.
16.3.13. EKF Diagnostics Holdings plc
16.3.14. OSANG Healthcare Co. Ltd
16.3.15. PTS Diagnostics
16.3.16. Roche Diagnostics
16.3.17. Siemens Healthineers
16.3.18. Tosoh Bioscience, Inc.
16.3.19. Trinity Biotech plc
  • INQUIRE BEFORE BUYING